Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis

Jiwon Yang,Won-Mook Choi,Ju Hyun Shim,Danbi Lee,Kang Mo Kim,Young-Suk Lim,Han Chu Lee,Jonggi Choi
DOI: https://doi.org/10.14309/ajg.0000000000002181
2023-01-11
Abstract:The initiation of antiviral treatment in chronic hepatitis B (CHB) patients with compensated cirrhosis and low-level viremia (LLV; HBV DNA 15–2,000 IU/mL) remains controversial. We sought to compare the long-term outcomes of these untreated patients according to their viremic status.
What problem does this paper attempt to address?